These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35960098)

  • 1. Validation of the neutrophil-to-lymphocyte ratio as a new simple biomarker of adult onset Still's disease: A STROBE-Compliant prospective observational study.
    Daghor Abbaci K; Ait Hamadouche N; Otmani F; Dahou Makhloufi C; Mechid F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
    Medicine (Baltimore); 2022 Aug; 101(32):e29970. PubMed ID: 35960098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal of a new diagnostic algorithm for adult-onset Still's disease.
    Daghor-Abbaci K; Ait Hamadouche N; Makhloufi CD; Mechid F; Otmani F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
    Clin Rheumatol; 2023 Apr; 42(4):1125-1135. PubMed ID: 36694091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.
    Seo JY; Suh CH; Jung JY; Kim AR; Yang JW; Kim HA
    Medicine (Baltimore); 2017 Jul; 96(29):e7546. PubMed ID: 28723775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Fautrel classification criteria for adult-onset Still's disease.
    Lebrun D; Mestrallet S; Dehoux M; Golmard JL; Granger B; Georgin-Lavialle S; Arnaud L; Grateau G; Pouchot J; Fautrel B
    Semin Arthritis Rheum; 2018 Feb; 47(4):578-585. PubMed ID: 28760536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience.
    Lian F; Wang Y; Yang X; Xu H; Liang L
    Rheumatol Int; 2012 Jan; 32(1):189-92. PubMed ID: 20798946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
    Vanderschueren S; Hermans F; De Munter P; Knockaert D
    Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination value of biomarkers in discriminating adult onset Still's disease and sepsis.
    Zhang M; Xie M; Wang Y; Li J; Zhou J
    Wien Klin Wochenschr; 2021 Feb; 133(3-4):118-122. PubMed ID: 32430612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population.
    Jiang L; Wang Z; Dai X; Jin X
    J Rheumatol; 2011 Apr; 38(4):741-6. PubMed ID: 21285163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A series of 22 patients with adult-onset Still's disease presenting with fever of unknown origin. A difficult diagnosis?
    Baxevanos G; Tzimas T; Pappas G; Akritidis N
    Clin Rheumatol; 2012 Jan; 31(1):49-53. PubMed ID: 21603876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
    Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
    Front Immunol; 2021; 12():654811. PubMed ID: 33868298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
    Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
    J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult-onset Still's disease or systemic-onset juvenile idiopathic arthritis and spondyloarthritis: overlapping syndrome or phenotype shift?
    Mitrovic S; Hassold N; Kamissoko A; Rosine N; Mathian A; Mercy G; Pertuiset E; Nocturne G; Fautrel B; Koné-Paut I
    Rheumatology (Oxford); 2022 May; 61(6):2535-2547. PubMed ID: 34559214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis.
    Koga T; Sumiyoshi R; Furukawa K; Sato S; Migita K; Shimizu T; Umeda M; Endo Y; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nonaka F; Yachie A; Kondo H; Maeda T; Kawakami A
    Arthritis Res Ther; 2020 May; 22(1):108. PubMed ID: 32381117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
    Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
    Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage.
    Jia J; Yang L; Cao Z; Wang M; Ma Y; Ma X; Liu Q; Teng J; Shi H; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Liu T; Wang Z; Wan L; Yang C; Hu Q
    Rheumatology (Oxford); 2021 Jan; 60(1):304-315. PubMed ID: 32766690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients.
    Gerfaud-Valentin M; Maucort-Boulch D; Hot A; Iwaz J; Ninet J; Durieu I; Broussolle C; Sève P
    Medicine (Baltimore); 2014 Mar; 93(2):91-99. PubMed ID: 24646465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of clinical characteristics, laboratory tests, and serum ferritin in diagnosis of adult-onset Still disease.
    Sagy I; Finkel-Oron A; Naamany E; Barski L; Abu-Shakra M; Molad Y; Shiber S
    Medicine (Baltimore); 2022 Aug; 101(34):e30152. PubMed ID: 36042585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.